See the DrugPatentWatch profile for lipitor

Lipitor, a medication commonly prescribed to lower cholesterol levels, has not been directly linked to causing increased blood sugar levels. However, some studies suggest that statins, the class of drugs that Lipitor belongs to, might have a slight impact on glucose metabolism [1].

A study published in the Journal of the American College of Cardiology found that the use of statins was associated with a small increase in fasting glucose levels and hemoglobin A1c (HbA1c) levels, a measure of long-term blood sugar control [2]. However, the clinical significance of this increase is still a matter of debate among researchers.

The U.S. Food and Drug Administration (FDA) has also noted that some patients treated with statins may develop high blood sugar levels and type 2 diabetes, but the risk is small [3]. The FDA advises healthcare professionals to monitor patients treated with Lipitor and other statins for symptoms of increased blood sugar levels.

In conclusion, while Lipitor and other statins may have a slight impact on blood sugar levels, the risk is generally low. Patients taking Lipitor should monitor their blood sugar levels and consult their healthcare provider if they have any concerns.

Sources:
[1] DrugPatentWatch.com - Lipitor (Atorvastatin)
[2] J Am Coll Cardiol. 2010 May 4; 55(18): 1998–2007.
[3] FDA - FDA Drug Safety Communication: Important Safety Label Changes to Cholesterol-Lowering Statin Drugs

Note: DrugPatentWatch.com does not provide medical advice or information. Always consult a healthcare professional for medical advice.